COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 2616: Articles 26151-26160  | Next

G6PD variant distribution in sub-Saharan Africa and potential risks ofusing chloroquine/hydroxychloroquine based treatments forCOVID-19
da Rocha, J., Othman, H., Tiemessen, C. T., Botha, G., Ramsay, M., Masimirembwa, C., Adebamowo, C., Choudhury, A., Brandenburg, J.-T., Matshaba, M., Simo, G., Gamo, F.-J., Hazelhurst, S.
10.1101/2020.05.27.20114066 — Posted: 2020-06-02
Exhaled breath is a significant source of SARS-CoV-2 emission
Ma, J., Qi, X., Chen, H., Li, X., Zhan, Z., Wang, H., Sun, L., Zhang, L., Guo, J., Morawska, L., Grinshpun, S. A., Biswas, P., Flagan, R. C., Yao, M.
10.1101/2020.05.31.20115154 — Posted: 2020-06-02 Discussion: Onsite
Immunochromatographic assays for COVID-19 epidemiological screening: our experience
Bartolini, A., Scapaticci, M., Bioli, M., Lazzarotto, T., Re, M. C., Mancini, R.
10.1101/2020.05.28.20116046 — Posted: 2020-06-02
The Risk of Lifting COVID-19 Confinement in Mexico
Azanza Ricardo, C. L., Hernandez Vargas, E. A.
10.1101/2020.05.28.20115063 — Posted: 2020-06-02
How efficient are the lockdown measures taken for mitigating the Covid-19 epidemic?
Lasaulce, S., SATHEESKUMAR VARMA, V., Morarescu, C.
10.1101/2020.06.02.20120089 — Posted: 2020-06-02
Covid-19 testing strategies and lockdowns: the European closed curves, analysed by ``skew-normal'' distributions, the forecasts for the UK, Sweden, and the USA, and the ongoing outbreak in Brazil.
De Leo, S.
10.1101/2020.06.01.20119461 — Posted: 2020-06-02
Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction.
Wei, S., Kohl, E., Djandji, A., Morgan, S., Whittier, S., Mansukhani, M., Hod, E., D'Alton, M., Suh, Y., Williams, Z.
10.1101/2020.05.28.20115220 — Posted: 2020-06-02
Rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical trial and implementation study
Collier, D. A., Assennato, S. M., Sithole, N., Sharrocks, K., Ritchie, A., Ravji, P., Routledge, M., Sparkes, D., Skittrall, J., Warne, B., smielewska, A., RAMSEY, I., GOEL, N., CURRAN, M., ENOCH, D., TASSELL, R., LINEHAM, M., VAGHELA, D., LEONG, C., MOK, H. P., BRADLEY, J., SMITH, K. G., Mendoza, V., DEMIRIS, N., BESSER, M., DOUGAN, G., LEHNER, P. J., ZHANG, H., WADDINGTON, C., LEE, H., Gupta, R. K.
10.1101/2020.05.31.20114520 — Posted: 2020-06-02
A Simple, SIR-like but Individual-Based l-i AIR Model: Application in Comparison of COVID-19 in New York City and Wuhan
Liu, X.
10.1101/2020.05.28.20115121 — Posted: 2020-06-02
A SYSTEMATIC ANALYSIS OF THE TIME COURSE TO DEVELOP TREATMENTS FOR COVID-19
Ngo, B. T., Rendell, M.
10.1101/2020.05.27.20115238 — Posted: 2020-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).